Floatz logo

Xeomin®

Chronic Anal Fissure

State Scientific Centre of Coloproctology, Russian FederationN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Chronic Anal Fissure cohort.

Asset / SponsorPhaseRating
Nifedipine
RDD Pharma Ltd
Phase 2/3BB
Oxygen
Jay C. Buckey Jr.
Phase 4BB

Same molecule, other indications

Xeomin® is also rated in:

Muscle SpasticityDormant
BBB
Indicative ·
79 / 100
View asset →
Migraine DisordersDormant
BBB
Indicative ·
77 / 100
View asset →
stroke disorderDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →